Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Walsh

Showing results (521-530 of 561) with videos related to

Pageof 57
Sort By:
Reproductive Sciences (Thousand Oaks, Calif.)|June 20, 2020
Placental Production of Eicosanoids and Sphingolipids in Women Who Developed Preeclampsia on Low-Dose AspirinScott W Walsh, Daniel T Reep, S M Khorshed Alam, et al.
Cancer Chemotherapy and Pharmacology|March 11, 2006
A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors: IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials GroupG Goss, L L Siu, I Gauthier, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2009
Ultrasensitive genotypic detection of antiviral resistance in hepatitis B virus clinical isolatesJie Fang, Michael J Wichroski, Steven M Levine, et al.
Journal of Critical Care|July 30, 2011
Clinical factors associated with initiation of renal replacement therapy in critically ill patients with acute kidney injury-a prospective multicenter observational studySean M Bagshaw, Ron Wald, Jim Barton, et al.
The Journal of Emergency Medicine|April 18, 2014
Prednisone for emergency department low back pain: a randomized controlled trialBarnet Eskin, Richard D Shih, Frederick W Fiesseler, et al.
British Journal of Cancer|February 3, 2011
Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumoursA R A Razak, S J Hotte, L L Siu, et al.
Nature|January 25, 2013
Energy release in the solar corona from spatially resolved magnetic braidsJ W Cirtain, L Golub, A R Winebarger, et al.
Biochimica Et Biophysica Acta|January 24, 2012
Next-generation sequencing identifies TGF-β1-associated gene expression profiles in renal epithelial cells reiterated in human diabetic nephropathyEoin P Brennan, Melissa J Morine, David W Walsh, et al.
Investigational New Drugs|March 4, 2005
A phase I study of oral ZD 1839 given daily in patients with solid tumors: IND.122, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials GroupG Goss, H Hirte, W H Miller, et al.
Physiological Genomics|March 15, 2012
Effect of the metabolic environment at key stages of follicle development in cattle: focus on steroid biosynthesisS W Walsh, J P Mehta, P A McGettigan, et al.
Pageof 57

Showing results (521-530 of 561) with videos related to

Sort By:
Pageof 57
Reproductive Sciences (Thousand Oaks, Calif.)|June 20, 2020
Placental Production of Eicosanoids and Sphingolipids in Women Who Developed Preeclampsia on Low-Dose AspirinScott W Walsh, Daniel T Reep, S M Khorshed Alam, et al.
Cancer Chemotherapy and Pharmacology|March 11, 2006
A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors: IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials GroupG Goss, L L Siu, I Gauthier, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2009
Ultrasensitive genotypic detection of antiviral resistance in hepatitis B virus clinical isolatesJie Fang, Michael J Wichroski, Steven M Levine, et al.
Journal of Critical Care|July 30, 2011
Clinical factors associated with initiation of renal replacement therapy in critically ill patients with acute kidney injury-a prospective multicenter observational studySean M Bagshaw, Ron Wald, Jim Barton, et al.
The Journal of Emergency Medicine|April 18, 2014
Prednisone for emergency department low back pain: a randomized controlled trialBarnet Eskin, Richard D Shih, Frederick W Fiesseler, et al.
British Journal of Cancer|February 3, 2011
Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumoursA R A Razak, S J Hotte, L L Siu, et al.
Nature|January 25, 2013
Energy release in the solar corona from spatially resolved magnetic braidsJ W Cirtain, L Golub, A R Winebarger, et al.
Biochimica Et Biophysica Acta|January 24, 2012
Next-generation sequencing identifies TGF-β1-associated gene expression profiles in renal epithelial cells reiterated in human diabetic nephropathyEoin P Brennan, Melissa J Morine, David W Walsh, et al.
Investigational New Drugs|March 4, 2005
A phase I study of oral ZD 1839 given daily in patients with solid tumors: IND.122, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials GroupG Goss, H Hirte, W H Miller, et al.
Physiological Genomics|March 15, 2012
Effect of the metabolic environment at key stages of follicle development in cattle: focus on steroid biosynthesisS W Walsh, J P Mehta, P A McGettigan, et al.
Pageof 57